Delivery Order SPE2DB20D9226-SPE2DB24FQ62A

Award Date 8/26/24
Potential Completion Date 9/17/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $7,811.55 for the delivery of 4566993212 MIRENA 52 MG SYSTEMS. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,552.00, was awarded by the Defense Logistics Agency (DLA) on December 11, 2024 as a firm fixed-price delivery order. The contract covers the delivery of MIRENA 52 MG SYSTEMS, with a period of performance through January 3, 2025. This contract is not associated with any set-aside designation. As a key supplier to the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,129.72 contract is for the delivery of MIRENA 52 MG SYSTEMS. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables DLA to issue firm fixed-price...
This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,207.70 delivery order contract is for the supply of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract has a firm fixed price pricing type and a completion date of June 11, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,920.00 firm fixed-price delivery order is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with an ultimate completion date of April 16, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,104.00 Firm Fixed Price Delivery Order is for the supply of Mirena 52 mg Systems, a type of contraceptive device, with a period of performance through May 20, 2024. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $499,999,999, that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,124.68, is a firm fixed-price delivery order for the supply of MIRENA 52 MG SYSTEMS, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,552.00 delivery order contract was awarded by the Defense Logistics Agency (DLA) for the delivery of MIRENA 52 MG SYSTEMS, a contraceptive product. The contract has a firm fixed price pricing type and runs through May 20, 2024. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,368.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of MIRENA 52 MG SYSTEMS, a specialized pharmaceutical product, with a period of performance through January 8, 2025. This contract award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,696.00 firm fixed-price delivery order is for the supply of MIRENA 52 MG SYSTEMS, a type of contraceptive device, with an ultimate completion date of October 11, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB20D9226
    Indefinite Delivery Contract
  • SPE2DB20D9226-SPE2DB24FQ62A
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $8,880.00, is a firm fixed-price delivery order for the supply of MIRENA 52 MG SYSTEMS. The contract has a period of performance through September 17, 2024.

DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 1/9/25, 9:36 AM